Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4591 AL 4605

Early Development of Symptomatic Drugs in AD: A Systematic Review of the Use of Biomarkers

Deguil J, Ravasi L, Lamberty Y, Auffret A, Payoux P, Leroy C, Derambure P, Bordet R.

CNS Neurol Disord Drug Targets. 2016;15(7):823-36. doi: 10.2174/1871527315666160518124759.

Heterocyclic Scaffolds for the Treatment of Alzheimer's Disease

Martorana A, Giacalone V, Bonsignore R, Pace A, Gentile C, Pibiri I, Buscemi S, Lauria A, Piccionello AP.

Curr Pharm Des. 2016;22(26):3971-95. doi: 10.2174/1381612822666160518141650.

Metal Ions and Metal Complexes in Alzheimer's Disease

Spinello A, Bonsignore R, Barone G, Keppler BK, Terenzi A.

Curr Pharm Des. 2016;22(26):3996-4010. doi: 10.2174/1381612822666160520115248.

Effect of deoxyribonuclease I treatment for dementia in end-stage Alzheimer's disease: a case report

Tetz V, Tetz G.

J Med Case Rep. 2016 May 28;10(1):131. doi: 10.1186/s13256-016-0931-6.

Drug treatments in Alzheimer's disease

Briggs R, Kennelly SP, O'Neill D.

Clin Med (Lond). 2016 Jun;16(3):247-53. doi: 10.7861/clinmedicine.16-3-247.

Unexplained Homonymous Hemianopia

Balasubramaniam SC, Chen JJ.

JAMA Ophthalmol. 2016 Aug 1;134(8):935-6. doi: 10.1001/jamaophthalmol.2015.6112.

Genetic variants in Alzheimer disease - molecular and brain network approaches

Gaiteri C, Mostafavi S, Honey CJ, De Jager PL, Bennett DA.

Nat Rev Neurol. 2016 Jul;12(7):413-27. doi: 10.1038/nrneurol.2016.84. Epub 2016 Jun 10.

Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease?

Mander BA, Winer JR, Jagust WJ, Walker MP.

Trends Neurosci. 2016 Aug;39(8):552-566. doi: 10.1016/j.tins.2016.05.002. Epub 2016 Jun 17.

Big data to smart data in Alzheimer's disease: Real-world examples of advanced modeling and simulation

Haas M, Stephenson D, Romero K, Gordon MF, Zach N, Geerts H; Brain Health Modeling Initiative (BHMI).

Alzheimers Dement. 2016 Sep;12(9):1022-1030. doi: 10.1016/j.jalz.2016.05.005. Epub 2016 Jun 18.

Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device

Eyjolfsdottir H, Eriksdotter M, Linderoth B, Lind G, Juliusson B, Kusk P, Almkvist O, Andreasen N, Blennow K, Ferreira D, Westman E, Nennesmo I, Karami A, Darreh-Shori T, Kadir A, Nordberg A, Sundström E, Wahlund LO, Wall A, Wiberg M, Winblad B, Seiger Å, Wahlberg L, Almqvist P.

Alzheimers Res Ther. 2016 Jul 7;8(1):30. doi: 10.1186/s13195-016-0195-9.

Anti-Dementia Drugs, Gait Performance and Mental Imagery of Gait: A Non-Randomized Open-Label Trial

Beauchet O, Barden J, Liu-Ambrose T, Chester VL, Annweiler C, Szturm T, Grenier S, Léonard G, Bherer L, Allali G; Canadian Gait Consortium.

Drugs Aging. 2016 Sep;33(9):665-73. doi: 10.1007/s40266-016-0391-0.

Comprehensive effects of galantamine and cilostazol combination therapy on patients with Alzheimer's disease with asymptomatic lacunar infarction

Hishikawa N, Fukui Y, Sato K, Ohta Y, Yamashita T, Abe K.

Geriatr Gerontol Int. 2017 Oct;17(10):1384-1391. doi: 10.1111/ggi.12870. Epub 2016 Aug 31.

Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer's disease and elderly controls after oral administration of sembragiline

Sturm S, Forsberg A, Nave S, Stenkrona P, Seneca N, Varrone A, Comley RA, Fazio P, Jamois C, Nakao R, Ejduk Z, Al-Tawil N, Akenine U, Halldin C, Andreasen N, Ricci B.

Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):382-391. doi: 10.1007/s00259-016-3510-6. Epub 2016 Sep 16.

Meta-analysis of randomized, double-blind, placebo-controlled trials of melatonin in Alzheimer's disease

Wang YY, Zheng W, Ng CH, Ungvari GS, Wei W, Xiang YT.

Int J Geriatr Psychiatry. 2017 Jan;32(1):50-57. doi: 10.1002/gps.4571. Epub 2016 Sep 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias